arrow
返回
A

Alan H. Bryce

city of hope comprehensive cancer center

65H指数
425论文数
5.1W被引数
收录论文 70
发表时间
80 Real-World Outcomes and Clinicogenomic Factors Associated with Response to Tivozanib: A Multi-Center Study80 替沃扎尼治疗应答的真实世界结局及临床基因组学相关因素:一项多中心研究
err2026-09-02
err0
errOAAI
errJadon Fann; Yujun Li; Daniela Castro; Xiaochen Li; Bamidele Adesunloye; Abhishek Tripathi; Alexander Chehrazi-Raffle; Evan Pisick; Sandy Liu; Alan Bryce; Tanya Dorff; Sumanta Pal; Charles Nguyen
err分享
err收藏
SAFETY OF RUCAPARIB VS DOCETAXEL OR SECOND-GENERATION ANDROGEN RECEPTOR PATHWAY INHIBITOR THERAPY FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND A BRCA MUTATION IN TRITON3鲁卡帕利与多西他赛或第二代雄激素受体通路抑制剂治疗携带BRCA突变的TRITON3试验中转移性去势抵抗性前列腺癌患者的安全性比较
err2026-05-01
err0
PREAI
errGingerich, Joel R.; Bryce, Alan H.; Fizazi, Karim; Ryan, Charles J.; Chowdhury, Simon; Mellado, Begona; Misleh, Jamal; Peer, Avivit; Pfister, David; Rowe, Julie; Tagawa, Scott; McDermott, Ray; Piulats, Josep M.; Sridhar, Srikala S.; Abida, Wassim; Pliskin, Marc; Murphy, Susie; Hansen, Natalie; Pintus, Elias
err分享
err收藏
Comparative Survival in Metastatic Hormone-sensitive Prostate Cancer by Volume of Disease and Timing of Metastasis: A Living Network Meta-analysis比较性生存分析:激素敏感性转移性前列腺癌按疾病体积和转移时间划分——一项动态网络Meta分析
err2025-11-04
err0
PREAI
errIrbaz Bin Riaz; Syed Arsalan Ahmed Naqvi; Kunwer Sufyan Faisal; Huan He; Kaneez Zahra Rubab Khakwani; Daniel S. Childs; Jacob J. Orme; Praful Ravi; Parminder Singh; Syed A. Hussain; Kim Chi; Neeraj Agarwal; Axel S. Merseburger; Ian D. Davis; Andrew Armstrong; Maha H. Hussain; Matthew Smith; Gerhardt Attard; Bertrand Tombal; Karim Fizazi; Nick James; Aurelius Omlin; Silke Gillessen; Mohammad Hassan Murad; Eliezer M. Van Allen; Christopher J. Sweeney; Alan Haruo Bryce
err分享
err收藏
Real-World efficacy and safety of belzutifan in sporadic metastatic renal cell carcinoma: a multicenter study from the city of hope enterprisebelzutifan在散发性转移性肾细胞癌中的真实世界有效性与安全性:一项来自City of Hope Enterprise的多中心研究
err2025-10-01
err0
errOAAI
errNguyen, Charles; Nguyen, Kim; Ebrahimi, Hedyeh; Zugman, Miguel; Zang, Peter; Pisick, Evan; Kollimuttathuillam, Sudarsan; Mehta, Nilesh; Liu, Sandy; Tripathi, Abhishek; Chehrazi-Raffle, Alexander; Adesunloye, Bamidele; Bryce, Alan; Dorff, Tanya; Pal, Sumanta
err分享
err收藏
err分享
err收藏
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers
err2024-12-02
err0
errOAAI
errBarnett, Reagan M.; Jang, Albert; Lanka, Sree; Fu, Pingfu; Bucheit, Leslie A.; Babiker, Hani; Bryce, Alan; Meyer, Haley M.; Choi, Yujin; Moore, Casey; Garje, Rohan; Gao, Xin; Kim, Dae Won; Chang, Richard Y.; Gulhati, Pat; Ramaker, Ryne; Bansal, Rani; Zhang, Tian; Oliver Sartor, A.; Armstrong, Andrew J.; Bilen, Mehmet A.; Barata, Pedro
err分享
err收藏
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024对患有生物化学复发和晚期前列腺癌的男性实施循证策略: 来自美国前列腺癌会议2024的共识建议
errCANCER
IF5.1
err2024-12-01
err0
PREAI
errBryce, Alan H.; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H.; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Calais, Jeremie; Carducci, Michael A.; Dorff, Tanya Barauskas; Efstathiou, Jason A.; Gleave, Martin; Gomella, Leonard G.; Higano, Celestia; Hope, Thomas A.; Iagaru, Andrei; Morgans, Alicia K.; Morris, David S.; Morris, Michael J.; Petrylak, Daniel P.; Reiter, Robert E.; Rettig, Matthew B.; Ryan, Charles J.; Sellinger, Scott B.; Spratt, Daniel E.; Srinivas, Sandy; Tagawa, Scott T.; Taplin, Mary-Ellen; Yu, Evan Y.; Zhang, Tian; Mckay, Rana R.; Koo, Phillip J.; Crawford, E. David
err分享
err收藏
Recent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer近期和未来聚(ADP-核糖)聚合酶抑制剂在前列腺癌中的研究进展
err2024-12-01
err0
PREAI
errFrancesca Zacchi; Wassim Abida; Emmanuel S. Antonarakis; Alan H. Bryce; Elena Castro; Heather H. Cheng; Shahneen Shandhu; Joaquin Mateo
err分享
err收藏
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone- sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide3个月和7个月的前列腺特异性抗原水平可作为转移性激素敏感性前列腺癌总生存期的预后指标: SWOG S1216的结果,这是一项雄激素剥夺加Orteronel或比卡鲁胺的3期随机试验
err2024-10-01
err2
errOAAI
errParikh, Mamta; Tangen, Catherine; Hussain, Maha H. A.; Gupta, Shilpa; Callis, Sam; Jo, Yeonjung; Harzstark, Andrea; Paller, Channing J.; George, Saby; Zibelman, Matthew R.; Cheng, Heather H.; Maughan, Benjamin L.; Zhang, Jingsong; Pachynski, Russell K.; Bryce, Alan H.; Lin, Daniel W.; Quinn, David I.; Lerner, Seth P.; Thompson, Ian M.; Dorff, Tanya B.; Lara, Primo N.; Agarwal, Neeraj
err分享
err收藏
Germline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2)前列腺癌患者同源修复缺陷的种系和体细胞检测 (第1部分,共2部分)
err2024-10-01
err3
errOAAI
errArmstrong, Andrew J.; Taylor, Amy; Haffner, Michael C.; Abida, Wassim; Bryce, Alan H.; Karsh, Lawrence I.; Tagawa, Scott T.; Twardowski, Przemyslaw; Serritella, Anthony V.; Lang, Joshua M.
err分享
err收藏
Therapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2)前列腺癌患者同源修复缺陷检测的治疗意义 (2/2)
err2024-09-27
err1
errOAAI
errSerritella, Anthony V.; Taylor, Amy; Haffner, Michael C.; Abida, Wassim; Bryce, Alan; Karsh, Lawrence I.; Tagawa, Scott T.; Twardowski, Przemyslaw; Armstrong, Andrew J.; Lang, Joshua M.
err分享
err收藏
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer同时发生的BRCA2/SPOP突变可预测转移性去势抵抗性前列腺癌中特殊的聚 (ADP-核糖) 聚合酶抑制剂敏感性
err2024-08-01
err5
PREAI
errOrme, Jacob J.; Taza, Fadi; De Sarkar, Navonil; Tewari, Alok K.; Naqvi, Syed Arsalan; Riaz, Irbaz B.; Childs, Daniel S.; Omar, Noha; Adra, Nabil; Ashkar, Ryan; Cheng, Heather H.; Schweizer, Michael T.; Sokolova, Alexandra O.; Agarwal, Neeraj; Barata, Pedro; Sartor, Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E.; McClure, Heather; Taplin, Mary-Ellen; Aggarwal, Rahul; Sternberg, Cora N.; Vlachostergios, Panagiotis J.; Alva, Ajjai S.; Mehra, Niven; Nelson, Peter S.; Hwang, Justin; Dehm, Scott M.; Shi, Qian; Fleischmann, Zoe; Sokol, Ethan S.; Elliott, Andrew; Huang, Haojie; Bryce, Alan; Marshall, Catherine H.; Antonarakis, Emmanuel S.
err分享
err收藏
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer (Mar, 10.1038/s41391-024-00803-5, 2024)
err2024-04-20
err0
errOAAI
errShore, Neal D.; Antonarakis, Emmanuel S.; Ross, Ashley E.; Marshall, Catherine H.; Stratton, Kelly L.; Ayanambakkam, Adanma; Cookson, Michael S.; McKay, Rana R.; Bryce, Alan H.; Kaymakcalan, Marina D.
err分享
err收藏
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
err2024-03-02
err2
PREAI
errShore, Neal; Antonarakis, Emmanuel; Ross, Ashley; Marshall, Catherine; Stratton, Kelly; Ayanambakkam, Adanma; Cookson, Michael; McKay, Rana; Bryce, Alan; Kaymakcalan, Marina
err分享
err收藏
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis
err2024-02-10
err3
errOAAI
errMosalem, Osama; Tan, Winston; Bryce, Alan H.; Dronca, Roxana S.; Childs, Daniel S.; Pagliaro, Lance C.; Orme, Jacob J.; Kase, Adam M.
err分享
err收藏
Challenges in clinical trials for high-risk but curable prostate cancer
errCANCER
IF5.1
err2024-02-10
err1
PREAI
errDorff, Tanya Barauskas; Bryce, Alan H.
err分享
err收藏
Community advisory board members' perspectives on genetic literacy and patient-caregiver communication of prognostic genomics for localized prostate cancer
err2023-12-01
err0
PREAI
errCobran, Ewan K.; Turner, Jocelyn; Odedina, Folakemi; Bryce, Alan H.; Williams, Christopher; Rodriguez, Jose; Williams, Roger; Nathan, Woodrow; Bryant, Thomas, III; Nathan, LoveVonia; Husband, Laureen
err分享
err收藏
Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer
err2023-11-07
err0
errOAAI
errAhmed, Mohamed E.; Lee, Matthew S.; Mahmoud, Ahmed M.; Joshi, Vidhu B.; Gopalakrishna, Ajay; Bole, Raevti; Haloi, Rimki; Kendi, A. Tuba; Bold, Michael S.; Bryce, Alan H.; Karnes, Robert Jeffrey; Kwon, Eugene D.; Childs, Daniel S.; Andrews, Jack R.
err分享
err收藏
Prostate Cancer, Version 4.2023前列腺癌,版本4.2023
err2023-10-01
err138
errOAAI
errSchaeffer, Edward M.; Srinivas, Sandy; Adra, Nabil; An, Yi; Barocas, Daniel; Bitting, Rhonda; Bryce, Alan; Chapin, Brian; Cheng, Heather H.; D'Amico, Anthony Victor; Desai, Neil; Dorff, Tanya; Eastham, James A.; Farrington, Thomas A.; Gao, Xin; Gupta, Shilpa; Guzzo, Thomas; Ippolito, Joseph E.; Kuettel, Michael R.; Lang, Joshua M.; Lotan, Tamara; Mckay, Rana R.; Morgan, Todd; Netto, George; Pow-Sang, Julio M.; Reiter, Robert; Roach, Mack; Robin, Tyler; Rosenfeld, Stan; Shabsigh, Ahmad; Spratt, Daniel; Teply, Benjamin A.; Tward, Jonathan; Valicenti, Richard; Wong, Jessica Karen; Shead, Dorothy A.; Snedeker, Jenna; Freedman-Cass, Deborah A.
err分享
err收藏